Palivizumab prophylaxis during respiratory syncytial virus outbreak in the neonatal intensive care unit

Turkish Journal of Pediatrics

Volumn 55, Issue 2, 2013, Pages 237-238

  Alan, Serdar ^a   Çakir, Ufuk ^a   Erdeve, Ömer ^a   Atasay, Begüm ^a   Arsan, Saadet ^a  

^a Division of Neonatology   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PALIVIZUMAB;

ASSISTED VENTILATION; EPIDEMIC; GESTATIONAL AGE; HIGH RISK PATIENT; HOSPITAL HYGIENE; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LETTER; LOWER RESPIRATORY TRACT INFECTION; NEWBORN INTENSIVE CARE; POLYMERASE CHAIN REACTION; PREMATURITY; RESPIRATORY SYNCYTIAL VIRUS INFECTION;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; FEMALE; HUMANS; INFANT, PREMATURE; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 84880639864     PISSN: 00414301     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Öncel MY, Mutlu B, Kavurt S, et al. Respiratory syncytial virus prophylaxis in preterm infants: a cost- effectiveness study from Turkey. Turk J Pediatr 2012; 54: 344-351.
2. Turkish Neonatal Society (Ankara, Turkey). The seasonal variations of respiratory syncytial virus infections in Turkey: a 2-year epidemiological study. Turk J Pediatr 2012; 54: 216-222.
3. Alan S, Okulu E, Kilic A, Atasay B, Arsan B. Palivizumab use during respiratory syncytial virus outbreak in the neonatal intensive care unit. J Hosp Infect 2012; 81: 292-294.
4. Dizdar EA, Aydemir C, Erdeve O, et al. Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit. J Hosp Infect 2010; 75: 292-294.